» Articles » PMID: 30877136

Microbiome Diurnal Rhythmicity and Its Impact on Host Physiology and Disease Risk

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2019 Mar 17
PMID 30877136
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Host-microbiome interactions constitute key determinants of host physiology, while their dysregulation is implicated in a wide range of human diseases. The microbiome undergoes diurnal variation in composition and function, and this in turn drives oscillations in host gene expression and functions. In this review, we discuss the newest developments in understanding circadian host-microbiome interplays, and how they may be relevant in health and disease contexts. We summarize the molecular mechanisms by which the microbiome influences host function in a diurnal manner, and inversely describe how the host orchestrates circadian rhythmicity of the microbiome. Furthermore, we highlight the future perspectives and challenges in studying this new and exciting facet of host-microbiome interactions. Finally, we illustrate how the elucidation of the microbiome chronobiology may pave the way for novel therapeutic approaches.

Citing Articles

Chronotype and Cancer: Emerging Relation Between Chrononutrition and Oncology from Human Studies.

Godos J, Currenti W, Ferri R, Lanza G, Caraci F, Frias-Toral E Nutrients. 2025; 17(3).

PMID: 39940387 PMC: 11819666. DOI: 10.3390/nu17030529.


The circadian clock gene period regulates the composition and daily bacterial load of the gut microbiome in Drosophila melanogaster.

Battistolli M, Varponi I, Romoli O, Sandrelli F Sci Rep. 2025; 15(1):1016.

PMID: 39762344 PMC: 11704212. DOI: 10.1038/s41598-024-84455-4.


Dysrhythmic saliva microbiota in mobile phone addicts with sleep disorders and restored by acupuncture.

Mei Y, Yang K, Zhang L, Jin Y, Yang N, Yang H Front Psychiatry. 2024; 15:1335554.

PMID: 38957739 PMC: 11217316. DOI: 10.3389/fpsyt.2024.1335554.


Chronodisruption and Gut Microbiota: Triggering Glycemic Imbalance in People with Type 2 Diabetes.

Moreno-Cortes M, Meza-Alvarado J, Garcia-Mena J, Hernandez-Rodriguez A Nutrients. 2024; 16(5).

PMID: 38474745 PMC: 10934040. DOI: 10.3390/nu16050616.


Short-term effects of etifoxine on human gut microbiome in healthy men.

Manook A, Baghai T, Riebel M, Nothdurfter C, Schwarzbach J, Gessner A Front Neurosci. 2023; 17:1188847.

PMID: 38075272 PMC: 10704910. DOI: 10.3389/fnins.2023.1188847.


References
1.
Tahara Y, Yamazaki M, Sukigara H, Motohashi H, Sasaki H, Miyakawa H . Gut Microbiota-Derived Short Chain Fatty Acids Induce Circadian Clock Entrainment in Mouse Peripheral Tissue. Sci Rep. 2018; 8(1):1395. PMC: 5780501. DOI: 10.1038/s41598-018-19836-7. View

2.
Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A . Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metab. 2017; 25(5):1054-1062.e5. PMC: 5502730. DOI: 10.1016/j.cmet.2017.04.001. View

3.
Jacobson A, Lam L, Rajendram M, Tamburini F, Honeycutt J, Pham T . A Gut Commensal-Produced Metabolite Mediates Colonization Resistance to Salmonella Infection. Cell Host Microbe. 2018; 24(2):296-307.e7. PMC: 6223613. DOI: 10.1016/j.chom.2018.07.002. View

4.
Ridaura V, Faith J, Rey F, Cheng J, Duncan A, Kau A . Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013; 341(6150):1241214. PMC: 3829625. DOI: 10.1126/science.1241214. View

5.
Bashiardes S, Tuganbaev T, Federici S, Elinav E . The microbiome in anti-cancer therapy. Semin Immunol. 2017; 32:74-81. DOI: 10.1016/j.smim.2017.04.001. View